Nextremity Solutions, Inc. Announces Commercial Launch of Stratum™ MPJ Plating System


Nextremity Solutions, Inc., a strategic commercialization organization with a focus on the musculoskeletal space, located in “The Orthopedic Capital of the World,” Warsaw, Ind., has recently made commercially available the Stratum MPJ Plating System as an extension to its already successful Stratum Foot Plating System.

The Stratum MPJ Plating System provides surgeons with twelve total plates with both 0-degree and 7-degree options. These plates address issues in the first metatarsophalangeal joint, which is the joint between the first metatarsal and proximal phalanx of the foot. MPJ fusion surgery is intended to help relieve pain in the front of the foot for the patient in need of surgery.

Ryan Schlotterback, Chief Technology Officer of Nextremity Solutions said, “The team has done an excellent job of developing our Stratum plating technology. We are pleased with the recent clinical success with the Stratum MPJ system and the continued adoption by our surgeon customers. Surgeons appreciate the combination of features that allow for efficient trialing and placement of the plate with the ability to dial in desired compression prior to final fixation. The Stratum MPJ Plating System further builds on the Stratum family of plates and we are excited about the additional applications in the pipeline.”

The Stratum MPJ Plating System launch was preceded by the launches of the Stratum Foot Plating System, Stratum Lapidus Plating System, and InCore® Lapidus System. All of these systems address various deformities or traumatic injuries of the foot. Additionally, Nextremity Solutions notes that its success in product development is owed to its i3® Strategic Solutions micro-commercialization strategy.

“Over the last two and a half years we have remained passionately focused on our i3 Strategic Solutions strategy. This strategy is driven by our collaboration with surgeon designers and surgeon evaluators that are committed to the development and pre-market evaluation of innovative surgical solutions. The most recent integration of these technologies continues to validate our unique strategic commercialization model,” said Rod Mayer, President & Chief Executive Officer for Nextremity Solutions.

The Nextremity Solutions Stratum Foot Plating System, which includes the Lapidus and MPJ plating systems, is a plate and screws construct indicated for fixation of fractures, osteotomies, non-unions, malunions and fusions of small bones and small bone segments, particularly in osteopenic bone. An application for a CE mark is pending.

The Nextremity Solutions InCore Lapidus System is a three-part construct intended for internal fixation for First Metatarsocuneiform arthrodesis (also known as Lapidus or First Tarsometatarsal Fusion).

To learn more about these products, visit http://www.nextremity.com.

About Nextremity Solutions, Inc.

Nextremity Solutions, Inc. is a privately held strategic commercialization organization with a focus on the musculoskeletal space, offering innovative solutions and Revenue Ready® products for various musculoskeletal applications and for the benefit of our industry partners. The Company’s procedure-ready, sterile implant systems include uniquely precise, proprietary technology designed to achieve repeatable and superior clinical outcomes.

For further information, visit http://www.nextremitysolutions.com or call Dave Temple, Executive Director of Marketing & Communications at 574-635-3022.

Print Friendly, PDF & Email

Chris J. Stewart

Chris currently serves as Chief Executive Officer of Surgio Health as well as COO at Ortho Spine Partners. Chris has close to 20 years of healthcare management experience with an infinity to improve healthcare delivery through the development and implementation of innovative solutions that solve real problems that result in improved efficiencies, reduction of unnecessary financial & clinical variation, and help drive better patient outcomes. Previously, Chris was assistant vice president and business unit leader for HPG/HCA. He has presented at numerous healthcare forums on topics that include disruptive innovation, physician engagement, shifting reimbursement models, cost per clinical episode and the future of supply chain delivery.

Related Articles

Back to top button